EMitool: Explainable Multi-Omics Integration for Disease Subtyping
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094268 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yong Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Bioinformatics and Computational Biology, The Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Sha…. Hauptthemen laut MEDLINE: Neoplasms, Genomics, Computational Biology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Science and Technology Major Project, Beihang University & Capital Medical University Plan, National Key Research and Development Program of China.
Abstract (Originalsprache)
Disease subtyping is essential for personalized medicine, enabling tailored treatment strategies based on disease heterogeneity. Advances in high-throughput technologies have led to the rapid accumulation of multi-omics data, driving the development of integration methods for comprehensive disease subtyping. However, existing approaches often lack explainability and fail to establish clear links between subtypes and clinical outcomes. To address these challenges, we developed EMitool, an explainable multi-omics integration tool that leverages a network-based fusion strategy to achieve biologically and clinically relevant disease subtyping without requiring prior clinical information. Using data from 31 cancer types in The Cancer Genome Atlas (TCGA), EMitool demonstrated superior subtyping accuracy compared to eight state-of-the-art methods. It also provides contribution scores for different omics data types, enhancing interpretability. EMitool-derived subtypes exhibited significant associations with the overall survival, pathological stage, tumor mutational burden, immune microenvironment characteristics, and therapeutic responses. Specifically, in kidney renal clear cell carcinoma (KIRC), EMitool identified three distinct subtypes with varying prognoses, immune cell compositions, and drug sensitivities. These findings highlight its potential for biomarker discovery and precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Bioinformatics and Computational Biology, The Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai 200241, China.
- Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai 200032, China.
- Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing 100083, China.
- Key Laboratory of Advanced Theory and Application in Statistics and Data Science-MOE, School of Statistics, East China Normal University, Shanghai 200062, China.
Förderung
- Shanghai Municipal Science and Technology Major Project
- Beihang University & Capital Medical University Plan
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Open Research Fund of Key Laboratory of Advanced Theory and Application in Statistics and Data Science-MOE, ECNU and Key Laboratory of MEA, and Ministry of Edu…
Zitieren
APA
Xu, Y., Wu, J., Chen, C., Ouyang, J., Li, D., & Shi, T. (2025). EMitool: Explainable Multi-Omics Integration for Disease Subtyping. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094268
Vancouver
Xu Y, Wu J, Chen C, Ouyang J, Li D, Shi T. EMitool: Explainable Multi-Omics Integration for Disease Subtyping. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094268
BibTeX
@article{Xu2025,
author = {Xu, Yong and Wu, Jun and Chen, Chen and Ouyang, Jian and Li, Dawei and Shi, Tieliu},
title = {EMitool: Explainable Multi-Omics Integration for Disease Subtyping},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094268}
}
EUVIMED